Content about Public domain

October 23, 2012
United Therapeutics awaits FDA decision on oral PAH drug as Sandoz seeks generic approval

The Food and Drug Administration is expected to decide at the end of this week whether to approve a new oral drug for pulmonary arterial hypertension made by United Therapeutics.

October 10, 2012
FDA approves generic cardiovascular drug

The Food and Drug Administration has approved a generic drug for treating blood pressure and chest pain.

September 18, 2012
Generics saved U.S. $1 trillion in 9 years

A trillion of anything is difficult to wrap one’s head around, whether it’s the number of grains of sand on a beach or stars in the sky. It’s so much easier for the human mind to look at such a quantity as the sum of its parts rather than on the basis of its individual components.


September 18, 2012
Mergers among generics cos. on the rise

Over the last few years of DSN’s coverage of the impending patent cliff and how it would affect the generic drug industry, IMS Health VP industry relations Doug Long predicted that the gradual commoditization of primary care drugs — long the lifeblood of generic drug makers — would lead to consolidation of the industry.


September 18, 2012
PDUFA, GDUFA make 2012 milestone year

2012 is turning out to be a pretty important year for generic drugs, important enough that some of the things happening over the past several months have begged comparison to 1984, probably the biggest milestone year for the industry.


August 15, 2012
Watson sues FDA over generic Actos

Watson Pharmaceuticals is suing the Food and Drug Administration, alleging that an agency decision would improperly delay its release of a generic drug for diabetes, the company said Wednesday.

August 6, 2012
Winn-Dixie adds generic form of Plavix to generics prescription program

Winn-Dixie announced the generic form of Plavix (clopidogrel) now is available for $4 for 30-day and $10 for 90-day prescriptions as part of the company's prescription savings program.

July 30, 2012
Watson seeks approval for acne, bronchospasm drugs

Generic drug maker Watson Pharmaceuticals is challenging the patent protection on a drug for acne and a drug for bronchospasm, the company said Monday.

July 5, 2012
FDA gives tentative approval to generic hypertension drug

Actavis has received a preliminary approval for a generic drug for treating high blood pressure, the drug maker said Thursday.

May 29, 2012
Watson settles with Endo, Teikoku Seiyaku over generic version of Lidoderm patch

Generic drug maker Watson Pharmaceuticals has entered a settlement that will allow it to launch a generic patch used to treat post herpetic neuralgia, a pain disorder associated with shingles.

April 23, 2012
Watson launches authorized generic diabetes drug

Watson Pharmaceuticals announced the launch of an authorized generic version of a drug used to lower blood glucose in patients with Type 2 diabetes.

April 11, 2012
Prasco to market authorized generic Vancocin

Prasco Labs will market an authorized generic version of a drug used to treat diarrhea caused by a bacterial infection, the company said Wednesday.

March 19, 2012
Watson challenges Abbott patent on Niaspan

Watson Pharmaceuticals is challenging the patent protection on a drug made by Abbott for treating cholesterol, the company said.

January 20, 2012
80% of drug shortages are injectables, 80% are generics

One issue that is unlikely to see resolution this year is the growing problem of drug shortages. As of October 2011, the Food and Drug Administration and the American Society of Health Systems Pharmacists found shortages of 168 drugs.

January 20, 2012
Generics face new and long-standing issues

In the Feb. 7, 2011, issue, Drug Store News named three major issues that would define 2011 for the world of generic drugs. Those issues were drug safety, generic user fees and patent settlements.

November 15, 2011
GPhA urges congressional super committee not to ban patent settlements

The generic drug lobby is stepping up its efforts to persuade the congressional super committee to avoid adopting rules that would ban some patent settlements between branded and generic drug makers.

October 25, 2011
FTC staff report attacks branded-generic patent settlements

The Federal Trade Commission released a report Tuesday finding that drug companies entered 28 deals that the FTC called anticompetitive and said would increase healthcare costs for consumers and the government.

October 21, 2011
Senators urge congressional super committee to support 'pay-for-delay' ban

Two senators are trying to get the Joint Select Committee on Deficit Reduction to take up a bill that would ban so-called "pay-for-delay" patent settlements between brand and generic drug companies, according to published reports.

October 17, 2011
Lannett begins shipping three generic drugs

Lannett announced that it has begun shipping three generic drugs that recently were approved by the Food and Drug Administration.

July 25, 2011
CVS: Generics essential to reducing health costs

Health care is like precision engineering; tweaking one element ever so slightly can mean the difference between a healthy life and an early death or, in the case of drug spending, between nearly $50,000 and just north of $1,000.


July 25, 2011
ReportersNotebook — Chain Pharmacy, 8/1/11

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating deep vein thrombosis in patients undergoing knee or hip replacement surgery, a J&J subsidiary said.

May 16, 2011
Generic, authorized generic of Amrix launched

Drug maker Mylan has launched a generic treatment for muscle spasms, the company said Friday.

April 19, 2011
GPhA applauds new IMS Institute report

The main trade group for the generic drug industry is heralding a new cost analysis by the IMS Institute for Healthcare Informatics showing that generic drugs can reduce co-payments by up to 80%.

April 19, 2011
IMS Institute: Rx drug spend experiences slower growth

U.S. spending on drugs grew 2.3% to $307.4 billion in 2010, according to a new report by the IMS Institute for Healthcare Informatics, part of industry research firm IMS Health.

March 31, 2011
Aurobindo receives approval for generic Razadyne, Monopril

Indian generic drug maker Aurobindo has received two approvals from the Food and Drug Administration.

© 2013 Drug Store News. All Rights Reserved.